Comparison of treatment adherence among TB patients with and without COVID-19 in South India.

Autor:	Thamineni R; Department of Pharmacy Practice, Balaji College of Pharmacy, Ananthapuramu, 515 002, Andhra Pradesh, India., Pradeepkumar B; Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research, Ananthapuramu, 515 002, Andhra Pradesh, India., Padmapriya J C; Department of Pharmacy Practice, Balaji College of Pharmacy, Ananthapuramu, 515 002, Andhra Pradesh, India., Rajanandh M; Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Deemed to Be University, Kattankulathur, Chennai, 603 203, Tamil Nadu, India. Electronic address: mgr@srmist.edu.in.
Jazyk:	angličtina
Zdroj:	The Indian journal of tuberculosis [Indian J Tuberc] 2024; Vol. 71 Suppl 2, pp. S214-S220. Date of Electronic Publication: 2024 May 08.
DOI:	10.1016/j.ijtb.2024.05.001
Abstrakt:	Aim: The present study aimed to compare the adherence to anti-TB treatment among post-COVID-19 pulmonary TB cases and TB patients without a history of COVID-19 in South India. Methods: A prospective, cross sectional study was conducted in all drug-sensitive pulmonary tuberculosis patients in National TB Elimination Program. The research investigates the impact of the COVID-19 pandemic on TB management, considering both subjective and objective measures of adherence. Data were collected using a validated instrument for subjective assessment and urine metabolite testing for objective evaluation. Results: The results reveal significant differences (p < 0.05) between subjective and objective adherence measures, emphasizing the need for accurate and comprehensive assessment methods. However, there is no statistically significant difference (p > 0.05) in adherence to anti-TB treatment among post-COVID-19 pulmonary TB cases and TB patients without a history of COVID-19 in South India. The reason for non-adherence in both groups were ATT side effects, loss of daily wages, forgetting to take medication and lazy to take medications. Conclusion: The study concluded that there is no statistically significant difference (p > 0.05) in adherence to anti-TB treatment among post-COVID-19 pulmonary TB cases and TB patients without a history of COVID-19. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024. Published by Elsevier B.V.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu